NCT06258421

Brief Summary

The main aim of the study is to assess the situation and quality of life of desmoid patients. Impaired areas of quality of life and the associated factors are to be identified. The survey is planned as a cross-sectional study (patient survey). Prevalent and incident desmoid patients will be identified at the University Hospital Mannheim and checked for eligibility. Quality of life and patient-reported data are collected by means of written questionnaires. Medical data is collected from patient files in the clinics. The aim is to include 100 patients. Descriptive analyses of the variables collected and regression models are planned as statistical analysis.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Oct 2023

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2023

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

January 24, 2024

Completed
21 days until next milestone

First Posted

Study publicly available on registry

February 14, 2024

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 31, 2024

Completed
1 day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2024

Completed
Last Updated

August 24, 2025

Status Verified

February 1, 2024

Enrollment Period

11 months

First QC Date

January 24, 2024

Last Update Submit

August 22, 2025

Conditions

Keywords

Health-related Quality of LifeUnmet needsReturn to normal life

Outcome Measures

Primary Outcomes (1)

  • Health-related Quality of Life (EORTC C30)

    Health-Related Quality of Life Questionnaire

    baseline

Secondary Outcomes (3)

  • The Brief Pain Inventory (BPI)

    baseline

  • Reintegration to Normal Living (RNL) Index

    baseline

  • Supportive Care Needs Survey

    baseline

Study Arms (1)

Desmoid Tumor Patients

People who have been diagnosed with a desmoid tumor after the age of 18

Other: No Intervention

Interventions

Observatory Study

Desmoid Tumor Patients

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

People who have been diagnosed with a desmoid tumorafter the age of 18. Treatment at the Mannheim University Hospital or via SOS Desmoid e.V.

You may qualify if:

  • Desmoid diagnosis (primary neoplasia, all stages)
  • Age ≥18 years at diagnosis

You may not qualify if:

  • Inability to complete a structured questionnaire (insufficient language skills; dementia)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Universitätsklinikum Carl-Gustav-Carus Dresden

Dresden, Saxony, 01307, Germany

Location

MeSH Terms

Conditions

Desmoid Tumors

Condition Hierarchy (Ancestors)

FibromaNeoplasms, Fibrous TissueNeoplasms, Connective TissueNeoplasms, Connective and Soft TissueNeoplasms by Histologic TypeNeoplasms

Study Officials

  • Martin Eichler, Dr., M.Sc. / PHD

    Universitätsklinikum Carl-Gustav-Carus Dresden

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 24, 2024

First Posted

February 14, 2024

Study Start

October 1, 2023

Primary Completion

August 31, 2024

Study Completion

September 1, 2024

Last Updated

August 24, 2025

Record last verified: 2024-02

Data Sharing

IPD Sharing
Will not share

Locations